Open AccessEbola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae
Author(s) -
Stephanie M. LaVergne,
Saori Sakabe,
Lansana Kanneh,
Mambu Momoh,
Foday Al-Hassan,
Mohamed Yilah,
Augustine Goba,
John Demby Sandi,
Michael Gbakie,
Beatrice Cubitt,
Matthew L. Boisen,
Jessica Mayeux,
Ashley R. Smira,
Kayla Shore,
Iris Bica,
K. Michael Pollard,
Juan Carlos de la Torre,
Luis M. Branco,
Robert F. Garry,
Donald S. Grant,
John S. Schieffelin,
Michael B. A. Oldstone,
Brian M. Sullivan
Publication year - 2020
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiaa268
Subject(s) - ebola virus , immunology , antibody , t cell , medicine , virology , immune system , cd8 , antigen , pathogenesis , sierra leone , biology , virus , development economics , economics
Ebola virus (EBOV) disease has killed thousands of West and Central Africans over the past several decades. Many who survive the acute disease later experience post-Ebola syndrome, a constellation of symptoms whose causative pathogenesis is unclear.